$QNTA Medolife Rx Schedules Conference Call with I
Post# of 37059
(Total Views: 160)
Posted On: 12/27/2021 10:14:01 AM
$QNTA Medolife Rx Schedules Conference Call with Investment Community To Discuss Third Quarter 2021 Financial and Operational Results and New Updates
Medolife Rx, Inc. ("Medolife"
, a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), announced today that it has scheduled a conference call with investors for Tuesday, November 23rd.
Conference Call Topics:
Bi-annual visit and filing with Ministry of Environment;
Tony Hawk ad campaign;
257% increase in efficacy of Ibuprofen using proprietary polarization technique from internal study;
Update on comparative study on CBD muscle rub, which showed a significant efficacy increase caused by polarization technology;
Update on progress with the government of the Dominican Republic;
Update on FINRA on the name and symbol change;
Update on the AELIA comparative study;
Update on Mexico distribution;
Update on social media sales programs;
Update on big box retailer conversations;
New business verticals, such as polarized ribosomes.
https://finance.yahoo.com/news/medolife-rx-sc...00507.html
Medolife Rx, Inc. ("Medolife"
, a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), announced today that it has scheduled a conference call with investors for Tuesday, November 23rd. Conference Call Topics:
Bi-annual visit and filing with Ministry of Environment;
Tony Hawk ad campaign;
257% increase in efficacy of Ibuprofen using proprietary polarization technique from internal study;
Update on comparative study on CBD muscle rub, which showed a significant efficacy increase caused by polarization technology;
Update on progress with the government of the Dominican Republic;
Update on FINRA on the name and symbol change;
Update on the AELIA comparative study;
Update on Mexico distribution;
Update on social media sales programs;
Update on big box retailer conversations;
New business verticals, such as polarized ribosomes.
https://finance.yahoo.com/news/medolife-rx-sc...00507.html
(0)
(0)Scroll down for more posts ▼